SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-032466
Filing Date
2021-12-27
Accepted
2021-12-27 06:09:03
Documents
20
Period of Report
2021-12-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 82690
2 ex10-1.htm EX-10.1 323982
3 ex10-2.htm EX-10.2 144785
4 ex10-3.htm EX-10.3 157268
5 ex10-4.htm EX-10.4 123271
6 ex10-5.htm EX-10.5 57346
7 ex10-6.htm EX-10.6 95056
8 ex10-8.htm EX-10.8 104407
9 ex99-1.htm EX-99.1 20983
  Complete submission text file 0001493152-21-032466.txt   1488553

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE mrzm-20211227.xsd EX-101.SCH 3033
11 XBRL LABEL FILE mrzm-20211227_lab.xml EX-101.LAB 34476
12 XBRL PRESENTATION FILE mrzm-20211227_pre.xml EX-101.PRE 22595
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3283
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME INC (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 211518859
SIC: 2834 Pharmaceutical Preparations